These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29301780)

  • 1. Multiparametric Analysis of Permeability and ADC Histogram Metrics for Classification of Pediatric Brain Tumors by Tumor Grade.
    Vajapeyam S; Brown D; Johnston PR; Ricci KI; Kieran MW; Lidov HGW; Poussaint TY
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):552-557. PubMed ID: 29301780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.
    Jung SC; Yeom JA; Kim JH; Ryoo I; Kim SC; Shin H; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH; Choi SH
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1103-10. PubMed ID: 24384119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    Vajapeyam S; Brown D; Billups C; Patay Z; Vezina G; Shiroishi MS; Law M; Baxter P; Onar-Thomas A; Fangusaro JR; Dunkel IJ; Poussaint TY
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):718-724. PubMed ID: 32241771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
    Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
    Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among
    Tomura N; Kokubun M; Saginoya T; Mizuno Y; Kikuchi Y
    AJNR Am J Neuroradiol; 2017 Aug; 38(8):1520-1527. PubMed ID: 28619837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.
    Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH
    Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Processing of Dynamic Contrast-Enhanced MRI: Correlation of Advanced Pharmacokinetic Metrics with Tumor Grade in Pediatric Brain Tumors.
    Vajapeyam S; Stamoulis C; Ricci K; Kieran M; Poussaint TY
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):170-175. PubMed ID: 27633807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.
    Murakami R; Hirai T; Sugahara T; Fukuoka H; Toya R; Nishimura S; Kitajima M; Okuda T; Nakamura H; Oya N; Kuratsu J; Yamashita Y
    Radiology; 2009 Jun; 251(3):838-45. PubMed ID: 19318585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.
    Choi YS; Kim DW; Lee SK; Chang JH; Kang SG; Kim EH; Kim SH; Rim TH; Ahn SS
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2235-41. PubMed ID: 26338911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fractional motion diffusion model for grading pediatric brain tumors.
    Karaman MM; Wang H; Sui Y; Engelhard HH; Li Y; Zhou XJ
    Neuroimage Clin; 2016; 12():707-714. PubMed ID: 27761401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading of oligodendroglial tumors of the brain with apparent diffusion coefficient, magnetic resonance spectroscopy, and dynamic susceptibility contrast imaging.
    Naveed MA; Goyal P; Malhotra A; Liu X; Gupta S; Mangla M; Mangla R
    Neuroradiol J; 2018 Aug; 31(4):379-385. PubMed ID: 29469659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel Incoherent Motion MR Imaging of Pediatric Intracranial Tumors: Correlation with Histology and Diagnostic Utility.
    Kikuchi K; Hiwatashi A; Togao O; Yamashita K; Kamei R; Momosaka D; Hata N; Iihara K; Suzuki SO; Iwaki T; Honda H
    AJNR Am J Neuroradiol; 2019 May; 40(5):878-884. PubMed ID: 31023663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metrics.
    Rodriguez Gutierrez D; Manita M; Jaspan T; Dineen RA; Grundy RG; Auer DP
    Neuro Oncol; 2013 Aug; 15(8):981-9. PubMed ID: 23585630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating Low-Grade from High-Grade Intracranial Ependymomas: Comparison of Dynamic Contrast-Enhanced MRI and Diffusion-Weighted Imaging.
    Arevalo-Perez J; Yllera-Contreras E; Peck KK; Hatzoglou V; Yildirim O; Rosenblum MK; Holodny AI
    AJNR Am J Neuroradiol; 2024 Jul; 45(7):927-933. PubMed ID: 38782589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
    Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation.
    Kickingereder P; Sahm F; Wiestler B; Roethke M; Heiland S; Schlemmer HP; Wick W; von Deimling A; Bendszus M; Radbruch A
    AJNR Am J Neuroradiol; 2014 Aug; 35(8):1503-8. PubMed ID: 24722313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.